Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "RSE"

1400 News Found

Lupin receives tentative approval from USFDA for Canagliflozin Tablets
Drug Approval | November 24, 2023

Lupin receives tentative approval from USFDA for Canagliflozin Tablets

Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor


Prevest Denpro launches range of innovative oral hygiene products ‘Oradox’
News | November 23, 2023

Prevest Denpro launches range of innovative oral hygiene products ‘Oradox’

The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care


Mandaviya visits Jan Aushadhi stall at IITF
News | November 21, 2023

Mandaviya visits Jan Aushadhi stall at IITF

Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness


Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023
Policy | November 20, 2023

Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023

Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure


Brenntag Specialties and Zeochem expand collaboration for Pharma EMEA
Supply Chain | November 17, 2023

Brenntag Specialties and Zeochem expand collaboration for Pharma EMEA

Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels


Pfizer and Astellas' XTANDI approved by USFDA in earlier prostate cancer treatment setting
Drug Approval | November 17, 2023

Pfizer and Astellas' XTANDI approved by USFDA in earlier prostate cancer treatment setting

XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer


Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
News | November 13, 2023

Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr

he company posted total income during Q2 FY24 at Rs. 12.86 crore


Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
News | November 13, 2023

Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr

European operations' revenue grew 58.4% to Rs 599.7 crore


SMS Pharmaceuticals reports robust Q2FY24 operational performance
News | November 10, 2023

SMS Pharmaceuticals reports robust Q2FY24 operational performance

Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore